HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hans-Walter Pfister Selected Research

Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)

1/2018Mast Cells Are Activated by Streptococcus pneumoniae In Vitro but Dispensable for the Host Defense Against Pneumococcal Central Nervous System Infection In Vivo.
4/2014Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis.
1/2014Leukocyte attraction by CCL20 and its receptor CCR6 in humans and mice with pneumococcal meningitis.
10/2013Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.
6/2013High mobility group box 1 prolongs inflammation and worsens disease in pneumococcal meningitis.
11/2011The NLRP3 inflammasome contributes to brain injury in pneumococcal meningitis and is activated through ATP-dependent lysosomal cathepsin B release.
11/2010CXCL16 contributes to neutrophil recruitment to cerebrospinal fluid in pneumococcal meningitis.
3/2009Simvastatin attenuates leukocyte recruitment in experimental bacterial meningitis.
10/2008Myeloid Src kinases regulate phagocytosis and oxidative burst in pneumococcal meningitis by activating NADPH oxidase.
2/2007Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hans-Walter Pfister Research Topics

Disease

22Bacterial Meningitis
01/2021 - 01/2002
20Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
01/2018 - 01/2002
16Meningitis
01/2017 - 01/2002
10Infections
08/2015 - 10/2003
7Leukocytosis (Pleocytosis)
01/2018 - 04/2003
7Inflammation (Inflammations)
01/2017 - 01/2002
4Encephalitis (Encephalitis, Rasmussen)
02/2020 - 11/2010
4Hearing Loss (Hearing Impairment)
10/2013 - 04/2003
4Pneumococcal Infections
11/2010 - 01/2003
3Multiple Sclerosis
06/2015 - 04/2003
3Brain Injuries (Brain Injury)
11/2011 - 01/2007
3Viral Meningitis
11/2010 - 04/2003
3Brain Edema (Cerebral Edema)
01/2007 - 01/2003
2Seizures (Absence Seizure)
01/2021 - 01/2017
2Critical Illness (Critically Ill)
02/2020 - 03/2004
2Hemorrhage
04/2019 - 09/2018
2Disease Progression
01/2018 - 11/2011
2Lyme Disease (Disease, Lyme)
01/2017 - 05/2006
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
06/2015 - 01/2015
2Autoimmune Diseases (Autoimmune Disease)
06/2015 - 01/2015
2Stroke (Strokes)
01/2011 - 03/2004
2Central Nervous System Vasculitis
11/2010 - 09/2006
2Central Nervous System Infections (Central Nervous System Infection)
10/2008 - 06/2008
2Intracranial Hemorrhages (Intracranial Hemorrhage)
01/2005 - 01/2003
1Autoimmune Diseases of the Nervous System
02/2020
1Brain Abscess (Abscess, Brain)
05/2019
1Clinical Deterioration
04/2019
1Venous Thromboembolism
09/2018
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
09/2018
1Thrombocytopenia (Thrombopenia)
09/2018
1Aneurysm (Aneurysms)
09/2018
1Fever (Fevers)
01/2018
1Coma (Comas)
01/2017
1Intracranial Hypotension
01/2017
1Post-Lyme Disease Syndrome
08/2015
1Meningococcal Meningitis
07/2014
1Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
07/2014
1Cerebral Infarction
04/2014
1Body Weight (Weight, Body)
10/2013
1Neurologic Manifestations (Neurological Manifestations)
10/2013

Drug/Important Bio-Agent (IBA)

14Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 12/2002
10ChemokinesIBA
01/2014 - 12/2002
8CytokinesIBA
11/2011 - 12/2002
7Proteins (Proteins, Gene)FDA Link
07/2015 - 03/2002
5Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 12/2002
4Ceftriaxone (Ceftriaxon)FDA LinkGeneric
10/2013 - 10/2003
4Interleukin-1beta (Interleukin 1 beta)IBA
09/2006 - 01/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
02/2020 - 07/2014
3Toll-Like Receptors (Toll-Like Receptor)IBA
06/2010 - 04/2007
3Pattern Recognition ReceptorsIBA
06/2010 - 01/2003
3Interleukin-6 (Interleukin 6)IBA
01/2007 - 01/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2004 - 01/2002
3Messenger RNA (mRNA)IBA
06/2004 - 03/2002
2InflammasomesIBA
01/2017 - 11/2011
2Adenosine Triphosphate (ATP)IBA
01/2017 - 11/2011
2Biomarkers (Surrogate Marker)IBA
06/2015 - 11/2010
2Immunoglobulin G (IgG)IBA
06/2015 - 01/2015
2Plasminogen Activator Inhibitor 1IBA
04/2014 - 03/2005
2AntibodiesIBA
01/2014 - 11/2010
2Acetylcysteine (Siran)FDA LinkGeneric
10/2013 - 12/2006
2AntioxidantsIBA
10/2013 - 10/2003
2Toll-Like Receptor 2IBA
12/2009 - 01/2003
2Simvastatin (Zocor)FDA LinkGeneric
07/2009 - 03/2009
2Complement Receptors (Complement Receptor)IBA
10/2008 - 01/2003
2src-Family KinasesIBA
10/2008 - 01/2007
2Complement System Proteins (Complement)IBA
02/2007 - 06/2004
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2007 - 07/2005
2NitrogenIBA
12/2006 - 09/2006
2Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA
06/2004 - 01/2003
2Chemokine CX3CL1IBA
04/2003 - 02/2003
2Oxidants (Oxidizing Agents)IBA
12/2002 - 12/2002
2Peptide Hydrolases (Proteases)FDA Link
12/2002 - 12/2002
1Antiviral Agents (Antivirals)IBA
02/2020
1SteroidsIBA
02/2020
1Acyclovir (Aciclovir)FDA LinkGeneric
04/2019
1Heparin (Liquaemin)FDA LinkGeneric
09/2018
1Cromolyn Sodium (Cromoglicic Acid)FDA LinkGeneric
01/2018
1InterleukinsIBA
01/2017
1paquinimodIBA
07/2015
1Toll-Like Receptor 4IBA
07/2015
1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
06/2015
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2015
1LigandsIBA
01/2015
1TACI receptor-IgG Fc fragment fusion proteinIBA
01/2015
1Plasminogen Activators (Plasminogen Activator)IBA
04/2014
1ethyl pyruvateIBA
06/2013
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
02/2013
1Streptococcus pneumoniae plY proteinIBA
11/2011

Therapy/Procedure

20Therapeutics
01/2021 - 01/2002
3Critical Care (Surgical Intensive Care)
04/2007 - 01/2005
2Contraindications
01/2021 - 05/2008
2Decompressive Craniectomy
04/2019 - 03/2004
2Length of Stay
01/2018 - 01/2011
1Cesarean Section (Caesarean Section)
01/2017
1Conservative Treatment
01/2017
1Complementary Therapies (Alternative Medicine)
01/2017
1Epidural Anesthesia
01/2017
1Epidural Blood Patch
01/2017
1Aftercare (After-Treatment)
08/2015
1Spinal Injections
07/2015